PITTSBURGH--Cellomics, a company here whose drug discovery technology platform includes proprietary bioinformatics software, has raised $10.5 million in private venture funding. The venture syndicate was led by InterWest Partners and Axiom Venture Partners, along with Delphi Ventures and Oxford Bioscience Partners. Gerard Klauer Mattison served as investment consultants.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.